The Vascutek Rapidax™ II Post Market Surveillance Registry

NCT01977508 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2016-05-20

No results posted yet for this study

Summary

Multicentre, prospective, observational post-market registry. To monitor and collect data on the post-market clinical safety and performance of the Vascutek Rapidax II Vascular Access Graft.

Conditions

Interventions

DEVICE

ePTFE vascular access grafts

Sponsors & Collaborators

  • Vascutek Ltd.

    lead INDUSTRY

Principal Investigators

  • Bernd Lobenstein · Saale-Unstrut Klinikum Naumburg

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2016-05-31
Completion
2016-05-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01977508 on ClinicalTrials.gov